NOV
37
-2
EW
40
2
BMY
43
8
MET
60
2
GM
61
-4
SCHW
49
3
PRU
50
2
TGNA
58
4
FLR
36
-3
C
37
-2
MU
43
-4
MMM
30
2
WFC
58
-3
SRE
30
-2
SIG
47
-3
HSIC
44
4
FRT
38
-3
FCX
47
-9
AEP
56
-2
DRI
61
-2
NOV
37
-2
EW
40
2
BMY
43
8
MET
60
2
GM
61
-4
SCHW
49
3
PRU
50
2
TGNA
58
4
FLR
36
-3
C
37
-2
MU
43
-4
MMM
30
2
WFC
58
-3
SRE
30
-2
SIG
47
-3
HSIC
44
4
FRT
38
-3
FCX
47
-9
AEP
56
-2
DRI
61
-2
Financhill
Back

CureVac NV Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
30

CVAC
CureVac NV

Last Price:
3.36
Seasonality Move:
-21.94%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.85
Seasonality Move:
3.65%
Sell
30
CureVac NV (CVAC) is a Sell

Is CureVac NV a Buy, Sell or Hold?

  • The current CureVac NV [CVAC] share price is $3.26. The Score for CVAC is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CVAC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CVAC Stock Price Chart

What is CureVac NV's stock price today?

  • The CureVac NV share price today is $3.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CVAC is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CVAC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 41.31 Sell
Chaikin Money Flow: -71410 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.41 - 4.33) Sell
Bollinger Bands (100): (2.8 - 3.8) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

CVAC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.67 Sell
20-day SMA: 3.95 Sell
50-day SMA: 3.3 Sell
200-day SMA: 4.43 Sell
8-day EMA: 3.59 Sell
20-day EMA: 3.73 Sell
50-day EMA: 3.55 Sell
200-day EMA: 4.68 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

CureVac NV Earnings Growth & CVAC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.10 per share, an increase this year of $0.12 per share, and an increase next year of $0.43 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

CureVac NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):